Track topics on Twitter Track topics that are important to you
UK pharma major GlaxoSmithKline has filed for US approval for an expanded indication of its an interleukin-5…
Original Article: US regulatory submission for mepolizumab as EGPA treatmentNEXT ARTICLE
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...